0890 100 3 - WURTH ADHESIVE AND SEALING COMPOUND BLACK

Chemwatch Material Safety Data Sheet

Issue Date: 8-Sep-2008

NC317ECP

CHEMWATCH 4600-82

Version No:4

Section 1 - CHEMICAL PRODUCT AND COMPANY IDENTIFICATION

PRODUCT NAME

0890 100 3 - WURTH ADHESIVE AND SEALING COMPOUND BLACK

SYNONYMS

"bonding compound"

PRODUCT USE

Adhesive, sealant.

SUPPLIER

Company: Wurth Pty Ltd                
Address:                              
4 Redwood Drive (abn 48 002 487 096)  
Dingley                               
VIC, 3172                             
AUS                                   
Telephone: +61 3 9552 9552            
Telephone: 1800 331 603               
Emergency Tel: 1300 657 765           
Fax: +61 3 9551 2994                  
                                      

Section 2 - HAZARDS IDENTIFICATION

STATEMENT OF HAZARDOUS NATURE

HAZARDOUS SUBSTANCE. NON-DANGEROUS GOODS. According to the Criteria of
NOHSC, and the ADG Code.

POISONS SCHEDULE

None

 

RISK SAFETY
May cause SENSITISATION by inhalation. Wear suitable protective clothing.
Harmful to aquatic organisms may cause long-term adverse effects in the aquatic environment. Use only in well ventilated areas.
Keep container in a well ventilated place.
To clean the floor and all objects contaminated by this material use water and detergent.
Keep away from food drink and animal feeding stuffs.
If swallowed IMMEDIATELY contact Doctor or Poisons Information Centre (show this container or label).

 

Section 3 - COMPOSITION / INFORMATION ON INGREDIENTS

NAME CAS RN %
naphtha petroleum, heavy, hydrodesulfurised 64742-82-1. 1-2.5
xylene 1330-20-7 1-2.5
4, 4' - diphenylmethane diisocyanate (MDI) 101-68-8 0.1-0.9

Section 4 - FIRST AID MEASURES

SWALLOWED

· If swallowed do NOT induce vomiting.
· If vomiting occurs, lean patient forward or place on left side (head-down position, if possible) to maintain open
airway and prevent aspiration.
· Observe the patient carefully.
· Never give liquid to a person showing signs of being sleepy or with reduced awareness; i.e. becoming unconscious.
· Give water to rinse out mouth, then provide liquid slowly and as much as casualty can comfortably drink.
· Seek medical advice.

EYE

If this product comes in contact with the eyes:
· Wash out immediately with fresh running water.
· Ensure complete irrigation of the eye by keeping eyelids apart and away from eye and moving the eyelids by
occasionally lifting the upper and lower lids.
· If pain persists or recurs seek medical attention.
· Removal of contact lenses after an eye injury should only be undertaken by skilled personnel.

SKIN

If skin contact occurs:
· Immediately remove all contaminated clothing, including footwear.
· Flush skin and hair with running water (and soap if available).
· Seek medical attention in event of irritation.

INHALED

· If fumes or combustion products are inhaled remove from contaminated area.
· Lay patient down. Keep warm and rested.
· Prostheses such as false teeth, which may block airway, should be removed, where possible, prior to initiating
first aid procedures.
· Apply artificial respiration if not breathing, preferably with a demand valve resuscitator, bag-valve mask device,
or pocket mask as trained. Perform CPR if necessary.
· Transport to hospital, or doctor.

NOTES TO PHYSICIAN

For sub-chronic and chronic exposures to isocyanates:
· This material may be a potent pulmonary sensitiser which causes bronchospasm even in patients 
without prior airway hyperreactivity.
· Clinical symptoms of exposure involve mucosal irritation of respiratory and gastrointestinal 
tracts.
· Conjunctival irritation, skin inflammation (erythema, pain vesiculation) and gastrointestinal 
disturbances occur soon after exposure.
· Pulmonary symptoms include cough, burning, substernal pain and dyspnoea.
· Some cross-sensitivity occurs between different isocyanates.
· Noncardiogenic pulmonary edema and bronchospasm are the most serious consequences of exposure. 
Markedly symptomatic patients should receive oxygen, ventilatory support and an intravenous line.
· Treatment for asthma includes inhaled sympathomimetics (epinephrine [adrenalin], terbutaline) 
and steroids.
· Activated charcoal (1 g/kg) and a cathartic (sorbitol, magnesium citrate) may be useful for 
ingestion.
· Mydriatics, systemic analgesics and topical antibiotics (Sulamyd) may be used for corneal 
abrasions.
· There is no effective therapy for sensitised workers.
[Ellenhorn and Barceloux; Medical Toxicology]
NOTE: Isocyanates cause airway restriction in naive individuals with the degree of response 
dependant on the concentration and duration of exposure. They induce smooth muscle contraction 
which leads to bronchoconstrictive episodes. Acute changes in lung function, such as decreased 
FEV1, may not represent sensitivity.
[Karol & Jin, Frontiers in Molecular Toxicology, pp 56-61, 1992].
For acute or short term repeated exposures to xylene:
· Gastro-intestinal absorption is significant with ingestions. For ingestions exceeding 1-2 ml 
(xylene)/kg, intubation and lavage with cuffed endotracheal tube is recommended. The use of 
charcoal and cathartics is equivocal.
· Pulmonary absorption is rapid with about 60-65% retained at rest.
· Primary threat to life from ingestion and/or inhalation, is respiratory failure.
· Patients should be quickly evaluated for signs of respiratory distress (e.g. cyanosis, 
tachypnoea, intercostal retraction, obtundation) and given oxygen. Patients with inadequate tidal 
volumes or poor arterial blood gases (pO2 < 50 mm Hg or pCO2 > 50 mm Hg) should be intubated.
· Arrhythmias complicate some hydrocarbon ingestion and/or inhalation and electrocardiographic 
evidence of myocardial injury has been reported; intravenous lines and cardiac monitors should be 
established in obviously symptomatic patients. The lungs excrete inhaled solvents, so that 
hyperventilation improves clearance.
· A chest x-ray should be taken immediately after stabilisation of breathing and circulation to 
document aspiration and detect the presence of pneumothorax.
· Epinephrine (adrenalin) is not recommended for treatment of bronchospasm because of potential 
myocardial sensitisation to catecholamines. Inhaled cardioselective bronchodilators (e.g. Alupent, 
Salbutamol) are the preferred agents, with aminophylline a second choice.
BIOLOGICAL EXPOSURE INDEX - BEI
These represent the determinants observed in specimens collected from a healthy worker exposed at 
the Exposure Standard (ES or TLV):



Determinant Index Sampling Time Comments
Methylhippu-ric acids in urine 1.5 gm/gm creatinine End of shift
2 mg/min Last 4 hrs of shift
.

Section 5 - FIRE FIGHTING MEASURES

EXTINGUISHING MEDIA

· Foam.
· Dry chemical powder.
· BCF (where regulations permit).
· Carbon dioxide.
· Water spray or fog - Large fires only.

FIRE FIGHTING

· Alert Fire Brigade and tell them location and nature of hazard.
· Wear breathing apparatus plus protective gloves.
· Prevent, by any means available, spillage from entering drains or water courses.
· Use water delivered as a fine spray to control fire and cool adjacent area.
· DO NOT approach containers suspected to be hot.
· Cool fire exposed containers with water spray from a protected location.
· If safe to do so, remove containers from path of fire.
· Equipment should be thoroughly decontaminated after use.

FIRE/EXPLOSION HAZARD

Combustible. Will burn if ignited.
Combustion products include: carbon dioxide (CO2),  isocyanates,  and minor amounts of,
hydrogen cyanide,  hydrogen chloride,  phosgene,  nitrogen oxides (NOx),  other pyrolysis
products typical of burning organic material.

FIRE INCOMPATIBILITY

· Avoid contamination with oxidising agents i.e. nitrates, oxidising acids, chlorine
bleaches, pool chlorine etc. as ignition may result.

HAZCHEM:

Personal Protective Equipment

Gas tight chemical resistant suit.

Section 6 - ACCIDENTAL RELEASE MEASURES

EMERGENCY PROCEDURES

MINOR SPILLS

·  Clean up all spills immediately.
·  Avoid contact with skin and eyes.
·  Wear impervious gloves and safety goggles.
·  Trowel up/scrape up.
·  Place spilled material in clean, dry, sealed container.
·  Flush spill area with water.

MAJOR SPILLS

Minor hazard.
· Clear area of personnel.
· Alert Fire Brigade and tell them location and nature of hazard.
· Control personal contact by using protective equipment as required.
· Prevent spillage from entering drains or water ways.
· Contain spill with sand, earth or vermiculite.
· Collect recoverable product into labelled containers for recycling.
· Absorb remaining product with sand, earth or vermiculite and place in appropriate 
containers for disposal.
· Wash area and prevent runoff into drains or waterways.
· If contamination of drains or waterways occurs, advise emergency services.

 

Personal Protective Equipment advice is contained in Section 8 of the MSDS.

Section 7 - HANDLING AND STORAGE

PROCEDURE FOR HANDLING

· Avoid all personal contact, including inhalation.
· Wear protective clothing when risk of exposure occurs.
· Use in a well-ventilated area.
· Prevent concentration in hollows and sumps.
· DO NOT enter confined spaces until atmosphere has been checked.
· DO NOT allow material to contact humans, exposed food or food utensils.
· Avoid contact with incompatible materials.
· When handling, DO NOT eat, drink or smoke.
· Keep containers securely sealed when not in use.
· Avoid physical damage to containers.
· Always wash hands with soap and water after handling.
· Work clothes should be laundered separately. Launder contaminated clothing before re-use.
· Use good occupational work practice.
· Observe manufacturer's storing and handling recommendations.
· Atmosphere should be regularly checked against established exposure standards to ensure safe working conditions
are maintained.

SUITABLE CONTAINER

· Metal can or drum
· Packaging as recommended by manufacturer.
· Check all containers are clearly labelled and free from leaks.

STORAGE INCOMPATIBILITY

· Avoid reaction with oxidising agents.
· Keep dry.
· NOTE: May develop pressure in containers; open carefully. Vent periodically.

STORAGE REQUIREMENTS

· Store in original containers.
· Keep containers securely sealed.
· Store in a cool, dry, well-ventilated area.
· Store away from incompatible materials and foodstuff containers.
· Protect containers against physical damage and check regularly for leaks.
· Observe manufacturer's storing and handling recommendations.

Section 8 - EXPOSURE CONTROLS / PERSONAL PROTECTION

EXPOSURE CONTROLS

SourceMaterialTWA ppmTWA mg/m³STEL ppmSTEL mg/m³
________________________________________________________________
Australia Exposure Standardsnaphtha petroleum, heavy, hydrodesulfurised (White spirits)790
Australia Exposure Standardsxylene (Xylene (o-, m-, p- isomers))80350150655
Australia Exposure Standards4,4'-diphenylmethane diisocyanate (MDI) (Isocyanates, all (as-NCO))0.020.07
ENDOELTABLE

 

EMERGENCY EXPOSURE LIMITS

Material Revised IDLH Value (mg/m3) Revised IDLH Value (ppm)
naphtha petroleum, heavy, hydrodesulfurised 20,000
xylene 900
4,4'-diphenylmethane diisocyanate (MDI) 75

 

MATERIAL DATA

Not available. Refer to individual constituents.

INGREDIENT DATA

NAPHTHA PETROLEUM, HEAVY, HYDRODESULFURISED:
XYLENE:
   Sensory irritants are chemicals that produce temporary and undesirable side-effects on 
the eyes, nose or throat. Historically occupational exposure standards for these 
irritants have been based on observation of workers' responses to various airborne 
concentrations. Present day expectations require that nearly every individual should be 
protected against even minor sensory irritation and exposure standards are established 
using uncertainty factors or safety factors of 5 to 10 or more. On occasion animal no-
observable-effect-levels (NOEL) are used to determine these limits where human results 
are unavailable. An additional approach, typically used by the TLV committee (USA) in 
determining respiratory standards for this group of chemicals, has been to assign ceiling 
values (TLV C) to rapidly acting irritants and to assign short-term exposure limits (TLV 
STELs) when the weight of evidence from irritation, bioaccumulation and other endpoints 
combine to warrant such a limit. In contrast the MAK Commission (Germany) uses a five-
category system based on intensive odour, local irritation, and elimination half-life. 
However this system is being replaced to be consistent with the European Union (EU) 
Scientific Committee for Occupational Exposure Limits (SCOEL); this is more closely 
allied to that of the USA.
   OSHA (USA) concluded that exposure to sensory irritants can:
   · cause inflammation
   · cause increased susceptibility to other irritants and infectious agents
   · lead to permanent injury or dysfunction
   · permit greater absorption of hazardous substances and
   · acclimate the worker to the irritant warning properties of these substances thus 
increasing the risk of overexposure.

NAPHTHA PETROLEUM, HEAVY, HYDRODESULFURISED:
   Odour threshold: 0.25 ppm.
   The TLV-TWA is protective against ocular and upper respiratory tract irritation and is 
recommended for bulk handling of gasoline based on calculations of hydrocarbon content of 
gasoline vapour. A STEL is recommended to prevent mucous membrane and ocular irritation 
and prevention of acute depression of the central nervous system. Because of the wide 
variation in molecular weights of its components, the conversion of ppm to mg/m3 is 
approximate. Sweden recommends hexane type limits of 100 ppm and heptane and octane type 
limits of 300 ppm. Germany does not assign a value because of the widely differing 
compositions and resultant differences in toxic properties.
   Odour Safety Factor(OSF)
   OSF=0.042 (gasoline).
   Low and high odour thresholds of 5.25 and 157.5 mg/m3, respectively, were considered 
to provide a rather useful index of odour as a warning property.
   The TLV-TWA is calculated from data on the toxicities of the major ingredients and is 
intended to minimise the potential for irritative and narcotic effects, polyneuropathy 
and kidney damage produced by vapours.
   The NIOSH (USA) REL-TWA of 60 ppm is the same for all refined petroleum solvents. 
NIOSH published an occupational "action level" of 350 mg/m3 for exposure to Stoddard 
solvent, assuming a 10-hour work shift and a 40-hour work-week. The NIOSH-REL ceiling of 
1800 mg/m3 was established to protect workers from short-term effects that might produce 
vertigo or other adverse effects which might increase the risk of occupational accidents. 
Combined (gross) percutaneous absorption and inhalation exposure (at concentrations 
associated with nausea) are thought, by some, to be responsible for the development of 
frank hepatic toxicity and jaundice.
   ES TWA: 790 mg/m3 (as white spirit)
   TLV TWA: 100 ppm, 525 mg/m3 (as Stoddard Solvent)

XYLENE:
   IDLH Level: 900 ppm
   Odour Threshold Value: 20 ppm (detection), 40 ppm (recognition)
   NOTE: Detector tubes for o-xylene, measuring in excess of 10 ppm, are available 
commercially. (m-xylene and p-xylene give almost the same response).
   Xylene vapour is an irritant to the eyes, mucous membranes and skin and causes 
narcosis at high concentrations. Exposure to doses sufficiently high to produce 
intoxication and unconsciousness also produces transient liver and kidney toxicity. 
Neurologic impairment is NOT evident amongst volunteers inhaling up to 400 ppm though 
complaints of ocular and upper respiratory tract irritation occur at 200 ppm for 3 to 5 
minutes.
   Expos

4,4'-DIPHENYLMETHANE DIISOCYANATE (MDI):
   for diphenylmethane diisocyanate (methylene bisphenyl isocyanate; MDI)
   Odour Threshold Value: 0.39 ppm
   IDLH Level: 10 mg/m3
   Mean MDI exposures of less than 0.003 ppm appear to have no acute or chronic effect on 
pulmonary function.
   MDI produces identical toxicological responses to those produced by TDI and the 
recommended TLV-TWA is identical for the two isocyanates. Exposure at or below the 
recommended value is thought to protect the worker against pulmonary function decrements 
as well as to minimise the potential for respiratory tract sensitisation. Individuals who 
may be hypersusceptible or otherwise unusually responsive to exposure to certain 
industrial chemicals may not adequately protected from adverse health effects caused by 
MDI at the recommended TLV-TWA. Ceiling values recommended by NIOSH and OSHA are 
synonymous with normal excursions allowable for exposures to the TLV-TWA (in excess of 3 
x TLV-TWA for no more than a total of 30 minutes during a work day but in any case not 
exceeding 5 x TLV-TWA).

PERSONAL PROTECTION

EYE

· Safety glasses with side shields
· Chemical goggles.
· Contact lenses may pose a special hazard; soft contact lenses may absorb and 
concentrate irritants. A written policy document, describing the wearing of lens or 
restrictions on use, should be created for each workplace or task. This should include a 
review of lens absorption and adsorption for the class of chemicals in use and an account 
of injury experience. Medical and first-aid personnel should be trained in their removal 
and suitable equipment should be readily available. In the event of chemical exposure, 
begin eye irrigation immediately and remove contact lens as soon as practicable. Lens 
should be removed at the first signs of eye redness or irritation - lens should be 
removed in a clean environment only after workers have washed hands thoroughly. [CDC 
NIOSH Current Intelligence Bulletin 59].

HANDS/FEET

· Wear chemical protective gloves, eg. PVC.
· Wear safety footwear or safety gumboots, eg. Rubber.

OTHER

· Overalls.
· P.V.C. apron.
· Barrier cream.
· Skin cleansing cream.
· Eye wash unit.

RESPIRATOR

Respiratory protection may be required when ANY "Worst Case" vapour-phase concentration 
is exceeded (see Computer Prediction in "Exposure Standards").

Protection Factor Half-Face Respirator Full-Face Respirator
10 x ES A--AUS -
A--PAPR-AUS
50 x ES Air-line* -
100 x ES - A--3
100+ x ES - Air-line**
* - Continuous-flow; ** - Continuous-flow or positive pressure demand ^ - Full-face. The local concentration of material, quantity and conditions of use determine the type of personal protective equipment required. For further information consult site specific CHEMWATCH data (if available), or your Occupational Health and Safety Advisor.

ENGINEERING CONTROLS

Local exhaust ventilation usually required. If risk of overexposure exists, wear approved 
respirator. Correct fit is essential to obtain adequate protection. Supplied-air type 
respirator may be required in special circumstances. Correct fit is essential to ensure 
adequate protection.
An approved self contained breathing apparatus (SCBA) may be required in some situations.
Provide adequate ventilation in warehouse or closed storage area. 

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

APPEARANCE

Black paste with a characteristic odour; reacts with water.

PHYSICAL PROPERTIES

 

Molecular Weight: Not Applicable Boiling Range (ºC): Not Available
Melting Range (ºC): Not Available Specific Gravity (water=1): ~1.26
Solubility in water (g/L): Reacts pH (as supplied): Not Applicable
pH (1% solution): Not Applicable Vapour Pressure (kPa): Not Available
Volatile Component (%vol): 4.05 approx. Evaporation Rate: Not Available
Relative Vapour Density (air=1): Not Available Flash Point (ºC): >70
Lower Explosive Limit (%): Not Available Upper Explosive Limit (%): Not Available
Autoignition Temp (ºC): Not Available Decomposition Temp (ºC): Not Available
State: Non Slump Paste Viscosity: Not Available

Section 10 - CHEMICAL STABILITY AND REACTIVITY INFORMATION

CONDITIONS CONTRIBUTING TO INSTABILITY

Product is considered stable and hazardous polymerisation will not occur.

Section 11 - TOXICOLOGICAL INFORMATION

POTENTIAL HEALTH EFFECTS

ACUTE HEALTH EFFECTS

SWALLOWED

The material has NOT been classified by EC Directives or other classification systems as "harmful 
by ingestion". This is because of the lack of corroborating animal or human evidence. The material 
may still be damaging to the health of the individual, following ingestion, especially where pre-
existing organ (eg. liver, kidney) damage is evident. Present definitions of harmful or toxic 
substances are generally based on doses producing mortality rather than those producing morbidity 
(disease, ill-health). Gastrointestinal tract discomfort may produce nausea and vomiting. In an 
occupational setting however, ingestion of insignificant quantities is not thought to be cause for 
concern.

EYE

Although the material is not thought to be an irritant (as classified by EC Directives), direct 
contact with the eye may produce transient discomfort characterised by tearing or conjunctival 
redness (as with windburn).

SKIN

The material is not thought to produce adverse health effects or skin irritation following contact 
(as classified by EC Directives using animal models). Nevertheless, good hygiene practice requires 
that exposure be kept to a minimum and that suitable gloves be used in an occupational setting.
Open cuts, abraded or irritated skin should not be exposed to this material.
Entry into the blood-stream, through, for example, cuts, abrasions or lesions, may produce 
systemic injury with harmful effects. Examine the skin prior to the use of the material and ensure 
that any external damage is suitably protected.

INHALED

The material is not thought to produce adverse health effects or irritation of the respiratory 
tract (as classified by EC Directives using animal models). Nevertheless, good hygiene practice 
requires that exposure be kept to a minimum and that suitable control measures be used in an 
occupational setting.
Headache, fatigue, tiredness, irritability and digestive disturbances (nausea, loss of appetite 
and bloating) are the most common symptoms of xylene overexposure. Injury to the heart, liver, 
kidneys and nervous system has also been noted amongst workers. Temporary memory loss, kidney 
impairment, temporary confusion and some evidence of disturbance of liver function was reported in 
workers grossly exposed to xylene (1%). One death was noted, with autopsy revealing lung 
congestion, oedema and local bleeding of alveoli. Inhaling xylene at 100 ppm for 5-6 hours can 
increase reaction time and cause slight inco-ordination. Tolerance developed during the work week, 
but was lost over the weekend. Physical exercise may reduce tolerance. About 4-8% of total 
absorbed xylene accumulates in fat.

CHRONIC HEALTH EFFECTS

Inhaling this product is more likely to cause a sensitisation reaction in some persons compared to 
the general population.
Women exposed to xylene in the first 3 months of pregnancy showed a slightly increased risk of 
miscarriage and birth defects. Evaluation of workers chronically exposed to xylene has 
demonstrated lack of genetic toxicity. Exposure to xylene has been associated with increased rates 
of blood cancer, but this may be complicated by exposure to other substances, including benzene. 
Animal testing found no evidence of cancer-causing activity.

TOXICITY AND IRRITATION

Not available. Refer to individual constituents.

NAPHTHA PETROLEUM, HEAVY, HYDRODESULFURISED:
unless otherwise specified data extracted from RTECS - Register of Toxic Effects of Chemical Substances.

Lifetime exposure of rodents to gasoline produces carcinogenicity although the relevance to humans has been questioned. Gasoline induces kidney cancer in male rats as a consequence of accumulation of the alpha2- microglobulin protein in hyaline droplets in the male (but not female) rat kidney. Such abnormal accumulation represents lysosomal overload and leads to chronic renal tubular cell degeneration, accumulation of cell debris, mineralisation of renal medullary tubules and necrosis. A sustained regenerative proliferation occurs in epithelial cells with subsequent neoplastic transformation with continued exposure. The alpha2-microglobulin is produced under the influence of hormonal controls in male rats but not in females and, more importantly, not in humans. No data of toxicological significance identified in literature search. XYLENE: unless otherwise specified data extracted from RTECS - Register of Toxic Effects of Chemical Substances.
TOXICITY IRRITATION
Oral (human) LDLo: 50 mg/kg Skin (rabbit):500 mg/24h Moderate
Oral (rat) LD50: 4300 mg/kg Eye (human): 200 ppm Irritant
Inhalation (human) TCLo: 200 ppm Eye (rabbit): 87 mg Mild
Inhalation (man) LCLo: 10000 ppm/6h Eye (rabbit): 5 mg/24h SEVERE
Inhalation (rat) LC50: 5000 ppm/4h
Oral (Human) LD: 50 mg/kg
Inhalation (Human) TCLo: 200 ppm/4h
Intraperitoneal (Rat) LD50: 2459 mg/kg
Subcutaneous (Rat) LD50: 1700 mg/kg
Oral (Mouse) LD50: 2119 mg/kg
Intraperitoneal (Mouse) LD50: 1548 mg/kg
Intravenous (Rabbit) LD: 129 mg/kg
Inhalation (Guinea) pig: LC 450 ppm/4h
The material may produce severe irritation to the eye causing pronounced inflammation. Repeated or prolonged exposure to irritants may produce conjunctivitis. The material may cause skin irritation after prolonged or repeated exposure and may produce on contact skin redness, swelling, the production of vesicles, scaling and thickening of the skin. The substance is classified by IARC as Group 3: NOT classifiable as to its carcinogenicity to humans. Evidence of carcinogenicity may be inadequate or limited in animal testing. Reproductive effector in rats 4,4'-DIPHENYLMETHANE DIISOCYANATE (MDI): unless otherwise specified data extracted from RTECS - Register of Toxic Effects of Chemical Substances.
TOXICITY IRRITATION
Oral (rat) LDLo: 9200 mg/kg Skin (rabbit): 500 mg /24 hours
Inhalation (rat) LC50: 178 mg/m³/4h Dermal Sensitiser *
Oral (mouse) LD50: 2200 mg/kg Respiratory Sensitiser (g.pig) *
Dermal (rabbit) LD50: >6200 mg/kg * [* = Bayer CCINFO 2133615]
Oral (Rat) LD50: 9200 mg/kg
for diisocyanates: In general, there appears to be little or no difference between aromatic and aliphatic diisocyanates as toxicants. In addition, there are insufficient data available to make any major distinctions between polymeric (<1000 MW) and monomeric diisocyanates. Based on repeated dose studies in animals by the inhalation route, both aromatic and aliphatic diisocyanates appear to be of high concern for pulmonary toxicity at low exposure levels. Based upon a very limited data set, it appears that diisocyanate prepolymers exhibit the same respiratory tract effects as the monomers in repeated dose studies. There is also evidence that both aromatic and aliphatic diisocyanates are acutely toxic via the inhalation route. Most members of the diisocyanate category have not been tested for carcinogenic potential. Though the aromatic diisocyanates tested positive and the one aliphatic diisocyanate tested negative in one species, it is premature to make any generalizations about the carcinogenic potential of aromatic versus aliphatic diisocyanates. In the absence of more human data, it would be prudent at this time to assume that both aromatic and aliphatic diisocyanates are respiratory sensitisers. Diisocyanates are moderate to strong dermal sensitisers in animal studies. Skin irritation studies performed on rabbits and guinea pigs indicate no difference in the effects of aromatic versus aliphatic diisocyanates. For monomers, effects on the respiratory tract (lungs and nasal cavities) were observed in animal studies at exposure concentrations of less than 0.005 mg/L. The experimental animal data available on prepolymeric diisocyanates show similar adverse effects at levels that range from 0.002 mg/L to 0.026 mg/L. There is also evidence that both aromatic and aliphatic diisocyanates are acutely toxic via the inhalation route Oncogenicity: Most members of the diisocyanate category have not been tested for carcinogenic potential. Commercially available Poly-MDI was tested in a 2-year inhalation study in rats. The tested material contained 47% aromatic 4,4'-methylenediphenyl diisocyanate (MDI) and 53% higher molecular weight oligomers. Interim sacrifices at one year showed that males and females in the highest dose group (6 mg/m3) had treatment related histological changes in the nasal cavity, lungs and mediastinal lymph nodes. The incidence and severity of degeneration and basal cell hyperplasia of the olfactory epithelium and Bowman's gland hyperplasia were increased in males at the mid and high doses and in females at the high dose following the two year exposure period. Pulmonary adenomas were found in 6 males and 2 females, and pulmonary adenocarcinoma in one male in the high dose group. However, aliphatic hexamethylene diisocyanate (HDI) was found not to be carcinogenic in a two year repeated dose study in rats by the inhalation route. HDI has not been tested in mice by the inhalation route. Though the oral route is not an expected route of exposure to humans, it should be noted that in two year repeated dose studies by the oral route, aromatic toluene diisocyanate (TDI) and 3,3'-dimethoxy-benzidine-4, 4'-diisocyanate (dianisidine diisocyanate, DADI) were found to be carcinogenic in rodents. TDI induced a statistically significant increase in the incidence of liver tumors in rats and mice as well as dose- related hemangiosarcomas of the circulatory system and has been classified by the Agency as a B2 carcinogen. DADI was found to be carcinogenic in rats, but not in mice, with a statistically increase in the incidence of pancreatic tumors observed. Respiratory and Dermal Sensitization: Based on the available toxicity data in animals and epidemiologic studies of humans, aromatic diisocyanates such as TDI and MDI are strong respiratory sensitisers. Aliphatic diisocyanates are generally not active in animal models for respiratory sensitization. However, HDI and possibly isophorone diisocyanate (IPDI), are reported to be associated with respiratory sensitization in humans. Symptoms resulting from occupational exposure to HDI include shortness of breath, increased bronchoconstriction reaction to histamine challenges, asthmatic reactions, wheezing and coughing. Two case reports of human exposure to IPDI by inhalation suggest IPDI is a respiratory sensitiser in humans. In view of the information from case reports in humans, it would be prudent at this time to assume that both aromatic and aliphatic diisocyanates are respiratory sensitisers. Studies in both human and mice using TDI, HDI, MDI and dicyclohexylmethane-4,4'-diisocyanate (HMDI) suggest cross-reactivity with the other diisocyanates, irrespective of whether the challenge compound was an aliphatic or aromatic diisocyanate. Diisocyanates are moderate to strong dermal sensitisers in animal studies. There seems to be little or no difference in the level of reactivity between aromatic and aliphatic diisocyanates. Dermal Irritation: Skin irritation studies performed on rabbits and guinea pigs indicate no difference in the effects of aromatic versus aliphatic diisocyanates. The level of irritation ranged from slightly to severely irritating to the skin. One chemical, hydrogenated MDI (1,1-methylenebis-4-isocyanatocyclohexane), was found to be corrosive to the skin in guinea pigs. Contact allergies quickly manifest themselves as contact eczema, more rarely as urticaria or Quincke's oedema. The pathogenesis of contact eczema involves a cell-mediated (T lymphocytes) immune reaction of the delayed type. Other allergic skin reactions, e.g. contact urticaria, involve antibody-mediated immune reactions. The significance of the contact allergen is not simply determined by its sensitisation potential: the distribution of the substance and the opportunities for contact with it are equally important. A weakly sensitising substance which is widely distributed can be a more important allergen than one with stronger sensitising potential with which few individuals come into contact. From a clinical point of view, substances are noteworthy if they produce an allergic test reaction in more than 1% of the persons tested. Asthma-like symptoms may continue for months or even years after exposure to the material ceases. This may be due to a non-allergenic condition known as reactive airways dysfunction syndrome (RADS) which can occur following exposure to high levels of highly irritating compound. Key criteria for the diagnosis of RADS include the absence of preceding respiratory disease, in a non-atopic individual, with abrupt onset of persistent asthma-like symptoms within minutes to hours of a documented exposure to the irritant. A reversible airflow pattern, on spirometry, with the presence of moderate to severe bronchial hyperreactivity on methacholine challenge testing and the lack of minimal lymphocytic inflammation, without eosinophilia, have also been included in the criteria for diagnosis of RADS. RADS (or asthma) following an irritating inhalation is an infrequent disorder with rates related to the concentration of and duration of exposure to the irritating substance. Industrial bronchitis, on the other hand, is a disorder that occurs as result of exposure due to high concentrations of irritating substance (often particulate in nature) and is completely reversible after exposure ceases. The disorder is characterised by dyspnea, cough and mucus production. Allergic reactions involving the respiratory tract are usually due to interactions between IgE antibodies and allergens and occur rapidly. Allergic potential of the allergen and period of exposure often determine the severity of symptoms. Some people may be genetically more prone than others, and exposure to other irritants may aggravate symptoms. Allergy causing activity is due to interactions with proteins. Attention should be paid to atopic diathesis, characterised by increased susceptibility to nasal inflammation, asthma and eczema. Exogenous allergic alveolitis is induced essentially by allergen specific immune-complexes of the IgG type; cell-mediated reactions (T lymphocytes) may be involved. Such allergy is of the delayed type with onset up to four hours following exposure. Isocyanate vapours are irritating to the airways and can cause their inflammation, with wheezing, gasping, severe distress, even loss of consciousness and fluid in the lungs. Nervous system symptoms that may occur include headache, sleep disturbance, euphoria, inco-ordination, anxiety, depression and paranoia. Digestive effects include nausea and vomiting. Breathing difficulties may occur unpredictably after a period of tolerance and after skin contact. Allergic inflammation of the skin can occur, with rash, itching, blistering, and swelling of the hands and feet. Sensitive people can react to very low levels and should not be exposed to this material. The material may produce moderate eye irritation leading to inflammation. Repeated or prolonged exposure to irritants may produce conjunctivitis. The substance is classified by IARC as Group 3: NOT classifiable as to its carcinogenicity to humans. Evidence of carcinogenicity may be inadequate or limited in animal testing. Inhalation (human) TCLo: 0.13 ppm/30 mins Eye (rabbit): 0.10 mg moderate

 

MATERIAL CARCINOGEN REPROTOXIN SENSITISER SKIN
_______________ ____________ __________ __________ __________
xylene IARC:3 ILOEl
4,4'-diphenylmethane diisocyanate (MDI) IARC:3 ILOP AUOEL AUOELSk
CARCINOGEN IARC: International Agency for Research on Cancer (IARC) Carcinogens: xylene Category: The substance is classified by IARC as Group 3: NOT classifiable as to its carcinogenicity to humans. Evidence of carcinogenicity may be inadequate or limited in animal testing. REPROTOXIN ILOEl: ILO Chemicals in the electronics industry that have toxic effects on reproduction: xylene CARCINOGEN IARC: International Agency for Research on Cancer (IARC) Carcinogens: 4,4'-diphenylmethane diisocyanate (MDI) Category: The substance is classified by IARC as Group 3: NOT classifiable as to its carcinogenicity to humans. Evidence of carcinogenicity may be inadequate or limited in animal testing. REPROTOXIN ILOP: France Threshold Limit Values for Occupational Exposure (VLE, VME) - Allergens (French): 4,4'-diphenylmethane diisocyanate (MDI) SENSITISER AUOEL: Australia Exposure Standards - Sensitisers: 4,4'-diphenylmethane diisocyanate (MDI) SKIN AUOELSk: Australia Exposure Standards - Sensitisers: 4,4'-diphenylmethane diisocyanate (MDI)

Section 12 - ECOLOGICAL INFORMATION

DO NOT discharge into sewer or waterways.
WGK: Classification in accordance with German Water Resources Act.
Water hazard class 1 (self-assessment): slightly hazardous to water.
[Wurth]
Refer to data for ingredients, which follows:

NAPHTHA PETROLEUM, HEAVY, HYDRODESULFURISED:
Marine Pollutant:  Not Determined

Do NOT allow product to come in contact with surface waters or to intertidal areas below 
the mean high water mark. Do not contaminate water when cleaning equipment or disposing 
of equipment wash-waters.
Wastes resulting from use of the product must be disposed of on site or at approved waste 
sites.
The lower molecular weight hydrocarbons are expected to form a "slick" on the surface of 
waters after release in calm sea conditions. This is expected to evaporate and enter the 
atmosphere where it will be degraded through reaction with hydroxy radicals.

Some of the material will become associated with benthic sediments, and it is likely to 
be spread over a fairly wide area of sea floor. Marine sediments may be either aerobic or 
anaerobic. The material, in probability, is biodegradable, under aerobic conditions 
(isomerised olefins and alkenes show variable results). Evidence also suggests that the 
hydrocarbons may be degradable under anaerobic conditions although such degradation in 
benthic sediments may be a relatively slow process.

Under aerobic conditions the material will degrade to water and carbon dioxide, while 
under anaerobic processes it will produce water, methane and carbon dioxide.

Based on test results, as well as theoretical considerations, the potential for 
bioaccumulation may be high. Toxic effects are often observed in species such as blue 
mussel, daphnia, freshwater green algae, marine copepods and amphipods.
Drinking Water Standards: hydrocarbon total: 10 ug/l (UK max.).
DO NOT discharge into sewer or waterways.

XYLENE:
Fish LC50 (96hr.) (mg/l):                              13.5
BCF<100:                                               2.14- 2.20
log Kow (Prager 1995):                                 3.12- 3.20
Half- life Soil - High (hours):                        672
Half- life Soil - Low (hours):                         168
Half- life Air - High (hours):                         44
Half- life Air - Low (hours):                          2.6
Half- life Surface water - High (hours):               672
Half- life Surface water - Low (hours):                168
Half- life Ground water - High (hours):                8640
Half- life Ground water - Low (hours):                 336
Aqueous biodegradation - Aerobic - High (hours):       672
Aqueous biodegradation - Aerobic - Low (hours):        168
Aqueous biodegradation - Anaerobic - High (hours):     8640
Aqueous biodegradation - Anaerobic - Low (hours):      4320
Photolysis maximum light absorption - High (nano- m):  269.5
Photolysis maximum light absorption - Low (nano- m):   265
Photooxidation half- life water - High (hours):        2.70E+08
Photooxidation half- life water - Low (hours):         3.90E+05
Photooxidation half- life air - High (hours):          44
Photooxidation half- life air - Low (hours):           2.6

The lower molecular weight hydrocarbons are expected to form a "slick" on the surface of 
waters after release in calm sea conditions. This is expected to evaporate and enter the 
atmosphere where it will be degraded through reaction with hydroxy radicals.

Some of the material will become associated with benthic sediments, and it is likely to 
be spread over a fairly wide area of sea floor. Marine sediments may be either aerobic or 
anaerobic. The material, in probability, is biodegradable, under aerobic conditions 
(isomerised olefins and alkenes show variable results). Evidence also suggests that the 
hydrocarbons may be degradable under anaerobic conditions although such degradation in 
benthic sediments may be a relatively slow process.

Under aerobic conditions the material will degrade to water and carbon dioxide, while 
under anaerobic processes it will produce water, methane and carbon dioxide.

Based on test results, as well as theoretical considerations, the potential for 
bioaccumulation may be high. Toxic effects are often observed in species such as blue 
mussel, daphnia, freshwater green algae, marine copepods and amphipods.
Drinking Water Standards: hydrocarbon total: 10 ug/l (UK max.).
DO NOT discharge into sewer or waterways.
The material is classified as an ecotoxin* because the Fish LC50 (96 hours) is less than 
or equal to 0.1 mg/l

* Classification of Substances as Ecotoxic (Dangerous to the Environment)
  Appendix 8, Table 1
Compiler's Guide for the Preparation of International Chemical Safety Cards: 1993 
Commission of the European Communities.

4,4'-DIPHENYLMETHANE DIISOCYANATE (MDI):
Half- life Soil - High (hours):                     24
Half- life Soil - Low (hours):                      6
Half- life Air - High (hours):                      5.8
Half- life Air - Low (hours):                       0.58
Half- life Surface water - High (hours):            24
Half- life Surface water - Low (hours):             6
Half- life Ground water - High (hours):             24
Half- life Ground water - Low (hours):              6
Aqueous biodegradation - Aerobic - High (hours):    672
Aqueous biodegradation - Aerobic - Low (hours):     168
Aqueous biodegradation - Anaerobic - High (hours):  2688
Aqueous biodegradation - Anaerobic - Low (hours):   672
Photooxidation half- life air - High (hours):       5.8
Photooxidation half- life air - Low (hours):        0.58
First order hydrolysis half- life (hours):          12

Hydrolysis would represents the primary fate mechanism for the majority of the commercial 
isocyanate monomers, but, is tempered somewhat by the lack of water solubility. In the 
absence of hydrolysis, sorption to solids (e.g., sludge and sediments) will be the 
primary mechanism of removal. Biodegradation is minimal for most compounds and 
volatilisation is negligible. Atmospheric degradation is not expected with removal from 
air occurring by washout or dry deposition. Volatilisation from surface waters (e.g., 
lakes and rivers) is expected to take years. In wastewater treatment this process is not 
expected to be significant.
Review of the estimated properties of the isocyanates suggest that sorption is the 
primary removal mechanism in the ambient environment and in wastewater treatment in the 
absence of significant hydrolysis. Sorption to solids in wastewater treatment is 
considered strong to very strong for most compounds. Sorption to sediments and soils in 
the ambient environment is very strong in most instances. Migration to groundwater and 
surface waters is not expected due to sorption or hydrolysis.
Hydrolysis of the N=C=O will occur in less than hours in most instances and within 
minutes for more than 90% of the commercial isocyanates. However, the low to very low 
solubility of these substances will generally lessen the effectiveness of hydrolysis as a 
fate pathway. But hydrolysis should be considered one of the two major fate processes for 
the isocyanates.
Aerobic and/or anaerobic biodegradation of the isocyanates is not expected to occur at 
significant levels. Most of the substances take several months to degrade.
Degradation of the hydrolysis products will occur at varying rates depending on the 
moiety formed.
DO NOT discharge into sewer or waterways.
Toxicity Fish: LC50(96)95.24-134.37mg/L

Section 13 - DISPOSAL CONSIDERATIONS

· Recycle wherever possible or consult manufacturer for recycling options.
· Consult State Land Waste Authority for disposal.
· Bury or incinerate residue at an approved site.
· Recycle containers if possible, or dispose of in an authorised landfill.

Section 14 - TRANSPORTATION INFORMATION

HAZCHEM:

NOT REGULATED FOR TRANSPORT OF DANGEROUS GOODS: UN, IATA, IMDG

Section 15 - REGULATORY INFORMATION

POISONS SCHEDULE: None

REGULATIONS

0890 100 3 - Wurth Adhesive and Sealing Compound Black (CAS: None):
No regulations applicable

naphtha petroleum, heavy, hydrodesulfurised (CAS: 64742-82-1) is found on the following regulatory lists;
    Australia Hazardous Substances
    Australia Inventory of Chemical Substances (AICS)
    GESAMP/EHS Composite List of Hazard Profiles - Hazard evaluation of substances transported by ships
    International Council of Chemical Associations (ICCA) - High Production Volume List
    OECD Representative List of High Production Volume (HPV) Chemicals
naphtha petroleum, heavy, hydrodesulfurised (CAS: 8052-41-3) is found on the following regulatory lists;
    Australia Exposure Standards
    Australia Hazardous Substances
    Australia Inventory of Chemical Substances (AICS)
    Australia Standard for the Uniform Scheduling of Drugs and Poisons (SUSDP) - Appendix E (Part 2)
    Australia Standard for the Uniform Scheduling of Drugs and Poisons (SUSDP) - Schedule 5
    IMO Provisional Categorization of Liquid Substances - List 1: Pure or technically pure products
    IMO Provisional Categorization of Liquid Substances - List 2: Pollutant only mixtures containing at least 99% by weight of components already assessed by IMO
    International Air Transport Association (IATA) Dangerous Goods Regulations
    International Council of Chemical Associations (ICCA) - High Production Volume List
    OECD Representative List of High Production Volume (HPV) Chemicals
    OSPAR List of Chemicals for Priority Action

xylene (CAS: 1330-20-7) is found on the following regulatory lists;
    Australia - Australian Capital Territory - Environment Protection Regulation: Ambient environmental standards (Domestic water supply - organic compounds)
    Australia - Australian Capital Territory Environment Protection Regulation Pollutants entering waterways - Domestic water quality
    Australia Exposure Standards
    Australia Hazardous Substances
    Australia High Volume Industrial Chemical List (HVICL)
    Australia Inventory of Chemical Substances (AICS)
    Australia National Pollutant Inventory
    Australia Standard for the Uniform Scheduling of Drugs and Poisons (SUSDP) - Appendix E (Part 2)
    Australia Standard for the Uniform Scheduling of Drugs and Poisons (SUSDP) - Appendix F (Part 3)
    Australia Standard for the Uniform Scheduling of Drugs and Poisons (SUSDP) - Appendix I
    Australia Standard for the Uniform Scheduling of Drugs and Poisons (SUSDP) - Schedule 5
    Australia Standard for the Uniform Scheduling of Drugs and Poisons (SUSDP) - Schedule 6
    GESAMP/EHS Composite List of Hazard Profiles - Hazard evaluation of substances transported by ships
    IMO IBC Code Chapter 17: Summary of minimum requirements
    IMO MARPOL 73/78 (Annex II) - List of Noxious Liquid Substances Carried in Bulk
    IMO Provisional Categorization of Liquid Substances - List 1: Pure or technically pure products
    International Agency for Research on Cancer (IARC) Carcinogens
    International Air Transport Association (IATA) Dangerous Goods Regulations
    International Council of Chemical Associations (ICCA) - High Production Volume List
    OECD Representative List of High Production Volume (HPV) Chemicals
    WHO Guidelines for Drinking-water Quality - Guideline values for chemicals that are of health significance in drinking-water

4,4'-diphenylmethane diisocyanate (MDI) (CAS: 101-68-8) is found on the following regulatory lists;
    Australia - New South Wales Hazardous Substances Requiring Health Surveillance
    Australia - Queensland Hazardous Materials and Prescribed Quantities for Major Hazard Facilities
    Australia - Tasmania Hazardous Substances Requiring Health Surveillance
    Australia - Victoria Occupational Health and Safety Regulations - Schedule 9: Materials at Major Hazard Facilities (And Their Threshold Quantity) Table 2
    Australia - Western Australia Hazardous Substances Requiring Health Surveillance
    Australia Exposure Standards
    Australia Hazardous Substances
    Australia Hazardous Substances Requiring Health Surveillance
    Australia High Volume Industrial Chemical List (HVICL)
    Australia Inventory of Chemical Substances (AICS)
    Australia National Pollutant Inventory
    Australia Occupational Health and Safety (Commonwealth Employment) (National Standards) Regulations 1994 - Hazardous Substances Requiring Health Surveillance
    Australia Standard for the Uniform Scheduling of Drugs and Poisons (SUSDP) - Appendix E (Part 2)
    Australia Standard for the Uniform Scheduling of Drugs and Poisons (SUSDP) - Appendix F (Part 3)
    Australia Standard for the Uniform Scheduling of Drugs and Poisons (SUSDP) - Schedule 6
    GESAMP/EHS Composite List of Hazard Profiles - Hazard evaluation of substances transported by ships
    IMO MARPOL 73/78 (Annex II) - List of Noxious Liquid Substances Carried in Bulk
    International Agency for Research on Cancer (IARC) Carcinogens
    International Air Transport Association (IATA) Dangerous Goods Regulations
    OECD Representative List of High Production Volume (HPV) Chemicals
4,4'-diphenylmethane diisocyanate (MDI) (CAS: 26447-40-5) is found on the following regulatory lists;
    Australia - New South Wales Hazardous Substances Requiring Health Surveillance
    Australia - Tasmania Hazardous Substances Requiring Health Surveillance
    Australia - Victoria Occupational Health and Safety Regulations - Schedule 9: Materials at Major Hazard Facilities (And Their Threshold Quantity) Table 2
    Australia - Western Australia Hazardous Substances Requiring Health Surveillance
    Australia Exposure Standards
    Australia Hazardous Substances
    Australia Hazardous Substances Requiring Health Surveillance
    Australia Inventory of Chemical Substances (AICS)
    Australia Occupational Health and Safety (Commonwealth Employment) (National Standards) Regulations 1994 - Hazardous Substances Requiring Health Surveillance
    Australia Standard for the Uniform Scheduling of Drugs and Poisons (SUSDP) - Appendix E (Part 2)
    Australia Standard for the Uniform Scheduling of Drugs and Poisons (SUSDP) - Appendix F (Part 3)
    Australia Standard for the Uniform Scheduling of Drugs and Poisons (SUSDP) - Schedule 6
    OECD Representative List of High Production Volume (HPV) Chemicals

Section 16 - OTHER INFORMATION

Denmark Advisory list for selfclassification of dangerous substances

Substance                                 CAS         Suggested codes
4, 4' - diphenylmethane diisocyanate      26447- 40-  R43
(MDI)                                     5

 

INGREDIENTS WITH MULTIPLE CAS NUMBERS

Ingredient Name CAS
naphtha petroleum, heavy, hydrodesulfurised 64742-82-1, 8052-41-3
4,4'-diphenylmethane diisocyanate (MDI) 101-68-8, 26447-40-5

REPRODUCTIVE HEALTH GUIDELINES

Ingredient                 ORG                 UF      Endpoi  CR      Adeq
                                                       nt              TLV
xylene                     1.5 mg/m3           10      D       NA      -
These exposure guidelines have been derived from a screening level of risk assessment and 
should not be construed as unequivocally safe limits. ORGS represent an 8-hour time-
weighted average unless specified otherwise.
CR = Cancer Risk/10000; UF = Uncertainty factor:
TLV believed to be adequate to protect reproductive health:
LOD: Limit of detection
Toxic endpoints have also been identified as:
D = Developmental; R = Reproductive; TC = Transplacental carcinogen
Jankovic J., Drake F.: A Screening Method for Occupational Reproductive
American Industrial Hygiene Association Journal 57: 641-649 (1996).

EXPOSURE STANDARD FOR MIXTURES

"Worst Case" computer-aided prediction of vapour components/concentrations:
Composite Exposure Standard for Mixture (TWA) (mg/m3): 525 mg/m³
If the breathing zone concentration of ANY of the components listed below is exceeded, 
"Worst Case" considerations deem the individual to be overexposed.
Component  Breathing Zone ppm   Breathing Zone mg/m3  Mixture Conc: (%).

Component                                    Breathing zone  Breathing Zone  Mixture Conc
                                             (ppm)           (mg/m³)         (%)
naphtha petroleum, heavy, hydrodesulfurised  100.00          525.0000        2.5

 

Classification of the preparation and its individual components has drawn on official and
authoritative sources as well as independent review by the Chemwatch Classification
committee using available literature references.
A list of reference resources used to assist the committee may be found at:
www.chemwatch.net/references.

 

The (M)SDS is a Hazard Communication tool and should be used to assist in the Risk
Assessment. Many factors determine whether the reported Hazards are Risks in the
workplace or other settings. Risks may be determined by reference to Exposures Scenarios.
Scale of use, frequency of use and current or available engineering controls must be
considered.

 

This document is copyright. Apart from any fair dealing for the purposes of private study, research, review or
criticism, as permitted under the Copyright Act, no part may be reproduced by any process without written permission
from CHEMWATCH. TEL (+61 3) 9572 4700.

 

Issue Date: 8-Sep-2008

Print Date: 12-Sep-2008